biological_process

EPIGENETIC

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about EPIGENETIC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2279Connections

30Hypotheses

0Analyses

50Outgoing

50Incoming

20Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🧬 Biological Process Info

Name	EPIGENETIC
Key Genes/Proteins	ABCA1, APOE, AQP1

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Epigenetic Dysregulation in Neurodegeneration

mechanism · 4376 words

→

Pathway Diagram

graph TD
    EPIGENETIC["EPIGENETIC"] -->|"causes"| MICROGLIA["MICROGLIA"]
    style MICROGLIA fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    EPIGENETIC["EPIGENETIC"] -->|"activates"| PHAGOCYTOSIS["PHAGOCYTOSIS"]
    style PHAGOCYTOSIS fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    EPIGENETIC["EPIGENETIC"] -->|"promotes"| RAGE["RAGE"]
    style RAGE fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
    EPIGENETIC["EPIGENETIC"] -->|"exacerbates"| ISCHEMIC["ISCHEMIC"]
    style ISCHEMIC fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    EPIGENETIC["EPIGENETIC"] -->|"exacerbates"| STROKE["STROKE"]
    style STROKE fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    EPIGENETIC["EPIGENETIC"] -->|"activates"| UBIQUITIN["UBIQUITIN"]
    style UBIQUITIN fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
    EPIGENETIC["EPIGENETIC"] -->|"regulates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    style NEUROINFLAMMATION fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    DNA_METHYLATION["DNA METHYLATION"] -->|"causes"| EPIGENETIC["EPIGENETIC"]
    style DNA_METHYLATION fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    BDNF["BDNF"] -->|"promotes"| EPIGENETIC["EPIGENETIC"]
    style BDNF fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
    AUTOPHAGY["AUTOPHAGY"] -->|"targets"| EPIGENETIC["EPIGENETIC"]
    style AUTOPHAGY fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    APOPTOSIS["APOPTOSIS"] -->|"promotes"| EPIGENETIC["EPIGENETIC"]
    style APOPTOSIS fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    DNA_DAMAGE["DNA DAMAGE"] -->|"promotes"| EPIGENETIC["EPIGENETIC"]
    style DNA_DAMAGE fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    style EPIGENETIC fill:#5d4400,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold

Outgoing (148)

Target	Relation	Type	Str
Immune Response	interacts_with	pathway	0.55
Mtor	interacts_with	pathway	0.55
Dna Methylation	interacts_with	pathway	0.55
Synaptic Plasticity	interacts_with	pathway	0.55
Mitophagy	interacts_with	pathway	0.55
Apoptosis	interacts_with	pathway	0.55
Mapk	interacts_with	pathway	0.55
Insulin Signaling	interacts_with	pathway	0.55
Notch	interacts_with	pathway	0.55
Ferroptosis	interacts_with	pathway	0.55
Autophagy	interacts_with	pathway	0.55
Glycolysis	interacts_with	pathway	0.55
Jak-Stat	interacts_with	pathway	0.55
Hedgehog	interacts_with	pathway	0.55
Tgf-Β	interacts_with	pathway	0.55
Complement	interacts_with	pathway	0.55
Wnt	interacts_with	pathway	0.55
Ubiquitin-Proteasome	interacts_with	pathway	0.55
Macrophage	causes	cell_type	0.50
Monocyte	causes	cell_type	0.50
Hepatocyte	expressed_in	cell_type	0.50
Astrocyte	inhibits	cell_type	0.50
Neuron	inhibits	cell_type	0.50
Microglia	regulates	cell_type	0.50
TREM2	co_discussed	entity	0.50
NMDA	co_discussed	entity	0.50
NEURON	promotes	entity	0.50
OLIGODENDROCYTE	co_discussed	entity	0.50
ER STRESS	co_discussed	entity	0.50
INFLAMMASOME	co_discussed	entity	0.50
NLRP3	co_discussed	entity	0.50
PYROPTOSIS	co_discussed	entity	0.50
GABAergic	co_discussed	entity	0.50
INTERNEURON	co_discussed	entity	0.50
HUNTINGTON	co_discussed	entity	0.50
TNF	co_discussed	entity	0.50
PICALM	co_discussed	entity	0.50
GSK3B	co_discussed	entity	0.50
MONOCYTE	co_discussed	entity	0.50
MONOCYTES	co_discussed	entity	0.50
Neuron	associated_with	cell_type	0.50
Endothelial	associated_with	cell_type	0.50
Stem Cell	associated_with	cell_type	0.50
Macrophage	associated_with	cell_type	0.50
Fibroblast	associated_with	cell_type	0.50
T Cell	activates	cell_type	0.50
T Cell	associated_with	cell_type	0.50
Microglia	therapeutic_target	cell_type	0.50
Neuron	activates	cell_type	0.50
Dopaminergic	activates	cell_type	0.50

Incoming (2131)

Source	Relation	Type	Str
DNA	associated_with	gene	1.00
MICRORNAS	regulates	gene	1.00
Cancer	associated_with	disease	1.00
Tumor	inhibits	disease	1.00
Als	therapeutic_target	disease	1.00
OXIDATIVE STRESS	associated_with	gene	1.00
Tumor	regulates	disease	1.00
ALZHEIMER	activates	gene	1.00
Cancer	treats	disease	1.00
Als	expressed_in	disease	1.00
GENES	regulates	gene	1.00
Tumor	therapeutic_target	disease	1.00
Cancer	regulates	disease	1.00
DNA	therapeutic_target	gene	1.00
OVERVIEW	therapeutic_target	gene	1.00
Cancer	therapeutic_target	disease	1.00
AGING	regulates	gene	1.00
AGING	activates	gene	1.00
Inflammation	associated_with	entity	1.00
Tumor	activates	disease	1.00
AUTOPHAGY	regulates	gene	1.00
Cancer	inhibits	disease	1.00
OXIDATIVE STRESS	regulates	gene	1.00
INFLAMMATION	therapeutic_target	gene	1.00
CANCER	therapeutic_target	gene	1.00
MTOR	therapeutic_target	gene	1.00
Als	treats	disease	1.00
MIRNAS	regulates	gene	1.00
INFLAMMATION	regulates	gene	1.00
Aging	associated_with	disease	1.00
Aging	activates	disease	1.00
Inflammation	therapeutic_target	disease	1.00
AGING	associated_with	gene	1.00
CANCER	inhibits	gene	1.00
AUTOPHAGY	activates	gene	1.00
CANCER	activates	gene	1.00
CANCER	regulates	gene	1.00
ALZHEIMER'S DISEASE	associated_with	gene	1.00
AKT	therapeutic_target	gene	1.00
Als	associated_with	disease	1.00
Alzheimer	associated_with	disease	1.00
Aging	regulates	disease	1.00
GENES	associated_with	gene	1.00
INFLAMMATION	associated_with	gene	1.00
Fibrosis	therapeutic_target	disease	1.00
APOPTOSIS	therapeutic_target	gene	1.00
ALZHEIMER	associated_with	gene	1.00
PI3K	therapeutic_target	gene	1.00
CANCER	associated_with	gene	1.00
DNA	regulates	gene	1.00

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Nutrient-Sensing Epigenetic Circuit Reactivation	0.907	neurodegeneration	Epigenetic reprogramming in aging neuron
Epigenetic Priming Ketone Protocol	0.882	metabolic neuroscience	What determines the optimal timing and d
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A	0.790	neurodegeneration	epigenetic reprogramming aging neurons
Epigenetic Memory Erasure via TET2 Activation	0.741	neurodegeneration	Astrocyte reactivity subtypes in neurode
Astrocyte-Mediated Neuronal Epigenetic Rescue	0.725	neurodegeneration	Epigenetic reprogramming in aging neuron

Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Epigenetic	0.712	-	Blood-brain barrier permeability changes
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration	0.701	neurodegeneration	Epigenetic reprogramming in aging neuron
NAD+ Decline and SIRT1 Deficiency Drive Epigenetic Reprogram	0.700	neurodegeneration	What molecular mechanisms drive microgli
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat	0.690	neurodegeneration	CRISPR-based therapeutic approaches for
FOXO3-Longevity Pathway Epigenetic Reprogramming	0.672	neurodegeneration	Epigenetic clocks and biological aging i
EV-Mediated Epigenetic Reprogramming	0.665	neurodegeneration	Extracellular vesicle biomarkers for ear
EV-Mediated Epigenetic Reprogramming	0.661	neurodegeneration	Extracellular vesicle biomarkers for ear
NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinf	0.650	neurodegeneration	epigenetic reprogramming aging neurons
Loss of Homeostatic Epigenetic Identity Reprograms Microglia	0.650	neurodegeneration	What molecular mechanisms drive microgli
ELF2-Mediated OPC Epigenetic Drift Drives Region-Dependent M	0.650	Alzheimer disease	Allen Mouse Brain Aging Atlas: cross-age
Epigenetic Reprogramming of Microglial Memory	0.647	Alzheimer's disease	Neuroinflammation and microglial priming
Epigenetic Silencing of AIF1 Gene Locus by Chronic Inflammat	0.643	neuroinflammation	What causes IBA1 low/negative microglia
Partial OSK Reprogramming Reverses Epigenetic Aging Without	0.630	neurodegeneration	Investigate mechanisms of epigenetic rep
Epigenetic Bivalency at CDKN2A Locus Distinguishes Senescent	0.630	neurodegeneration	How can senescent microglia be molecular
Senescence-Associated Epigenetic Phenotype (SEP)	0.620	neurodegeneration	Comparative epigenetic signatures: DNA m
Epigenetic Memory Reprogramming for Alzheimer's Disease	0.611	neurodegeneration	CRISPR-based therapeutic approaches for
Female microglia exhibit heightened complement gene expressi	0.610	neurodegeneration	Synaptic pruning by microglia in neurode
Microglial priming is primarily epigenetic, with metabolic c	0.609	neuroinflammation	Do microglia actually switch between gly
Programmable Neuronal Circuit Repair via Epigenetic CRISPR	0.596	neurodegeneration	CRISPR-based therapeutic approaches for
Autophagy-Epigenetic Feedback Loop Creates a Compounding Bio	0.583	-	Epigenetic clocks as biomarkers for Alzh
REST Complex Dysregulation as Master Epigenetic Switch	0.570	neurodegeneration	Comparative epigenetic signatures: DNA m
H7: NEAT1 Epigenetic Rewiring Under Proteotoxic Stress	0.550	neurodegeneration	Investigate mechanisms of epigenetic rep
Circadian Epigenetic Ketone Synchronization Protocol	0.543	metabolic neuroscience	What determines the optimal timing and d
Epigenetic Reprogramming Required for Late-Stage Interventio	0.542	neurodegeneration	What is the optimal therapeutic window f
H6: Epigenetic Reset via APOE4→APOE3 Conversion Reverses Sen	0.540	neurodegeneration	Do APOE4-driven senescent astrocytes cau

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (20)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Gandouling protection against brain injury in Wilson's disease via SIR	validation	Hepatolenticular degeneration	0.900	0.00	TX mice (Wilson's disease mode	proposed	N/A
Epigenetic clocks association with brain aging patterns in older women	exploratory	cognitive impairment and demen	0.900	0.00	human patients	proposed	N/A
Tet2 modulation in Aβ42-injured mouse hippocampal neurons	exploratory	Alzheimer's disease	0.900	0.00	primary mouse hippocampal neur	proposed	N/A
AAV-mediated Tet2 modulation in 2×Tg-AD mice behavioral study	validation	Alzheimer's disease	0.900	0.00	young APPswe/PSEN1 double-tran	proposed	N/A
Acteoside treatment in LPS-induced SALI mouse model	validation	sepsis-associated acute lung i	0.900	0.00	LPS-induced SALI mouse model	proposed	N/A
Tet2 expression analysis in aged 2×Tg-AD mouse brains	exploratory	Alzheimer's disease	0.850	0.00	APPswe/PSEN1 double-transgenic	proposed	N/A
Nrf2 inhibitor ML385 mechanism validation experiment	exploratory	sepsis-associated acute lung i	0.850	0.00	RAW264.7 cells and/or mouse mo	proposed	N/A
Acteoside effects on RAW264.7 macrophage cells	exploratory	sepsis-associated acute lung i	0.850	0.00	RAW264.7 cells	proposed	N/A
Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecular Basis	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$6,550,000
Epigenetic Clocks in Neurodegeneration — Causal Drivers or Passive Mar	validation	Neurodegeneration	0.400	0.50	human	proposed	$3,000,000
Epigenetic Dysregulation Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,500,000
Lifestyle Intervention Mechanisms in Alzheimer's Disease	validation	Alzheimer's Disease	0.400	0.50	mouse	proposed	$430,000
Normal Aging to Alzheimer's Disease Transition Trigger — Identifying t	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$2,280,000
Sirtuin Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Sirtuin Pathway Dysfunction Validation in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Proposed experiment from debate on Epigenetic clocks and biological ag	falsification	Neurodegeneration	0.400	0.50	mouse	proposed	$450,000
CRISPR Gene Correction Approaches for CBS/PSP	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Proposed experiment from debate on Epigenetic clocks and biological ag	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$100,000
Epigenetic Dysregulation in Huntington's Disease — Therapeutic Targeti	validation	Neurodegeneration	0.400	0.50	human	proposed	$3,000,000
Epigenetic Regulation Dysfunction in Alzheimer's and Parkinson's Disea	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Clonal Hematopoiesis in Nonmalignant Disease: Functional Consequences of Mutated [PMID:40929507]	Koh Y, Tengesdal IW, Jaiswal S	Annu Rev Pathol	2026	1
Increased mitophagy protects cochlear hair cells from aminoglycoside-induced dam [PMID:35471096]	Zhang Y, Fang Q, Wang H, Qi J, Sun S, Li	Autophagy	2023	1
TET2 guards against unchecked BATF3-induced CAR T cell expansion. [PMID:36755094]	Jain N, Zhao Z, Feucht J, Koche R, Iyer	Nature	2023	1
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Futur [PMID:36928826]	Singh I, Singh A	Curr Oncol Rep	2023	1
The function and regulation of TET2 in innate immunity and inflammation. [PMID:33085059]	Cong B, Zhang Q, Cao X	Protein Cell	2021	1
Fifteen-minute consultation: Therapeutic hypothermia for infants with hypoxic is [PMID:31292147]	Cawley P, Chakkarapani E	Arch Dis Child Educ Pract Ed	2020	1
Axonal G3BP1 stress granule protein limits axonal mRNA translation and nerve reg [PMID:30135423]	Sahoo PK, Lee SJ, Jaiswal PB, Alber S, K	Nat Commun	2018	1
EB1 and EB3 regulate microtubule minus end organization and Golgi morphology. [PMID:28814570]	Yang C, Wu J, de Heus C, Grigoriev I, Li	J Cell Biol	2017	1
c-Rel Regulates Inscuteable Gene Expression during Mouse Embryonic Stem Cell Dif [PMID:26694615]	Ishibashi R, Kozuki S, Kamakura S, Sumim	J Biol Chem	2016	1
DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperate [PMID:24652652]	Polato F, Rusconi P, Zangrossi S, Morell	J Natl Cancer Inst	2014	1
Global epigenomic reconfiguration during mammalian brain development. [PMID:23828890]	Lister R, Mukamel EA, Nery JR, Urich M,	Science	2013	1
IRF4 addiction in multiple myeloma. [PMID:18568025]	Shaffer AL, Emre NC, Lamy L, Ngo VN, Wri	Nature	2008	1
TET1 deficiency amplifies macrophage inflammatory signaling associated with Croh [PMID:41896302]	["Perez R", "Paul R", "Kumar P", "Tutkun	Inflammation research : offici	2026	0
NAD+ subcellular partitioning mediated by miR-183 and miR-96 regulates muscle st [PMID:41915008]	Ma M, Ma R, Li Z, Shen S, Kong W, Qiu T,	Journal of molecular cell biol	2026	0
Tet methylcytosine dioxygenase 2(TET2)-dependent epigenetic regulation in the pa [PMID:41811389]	Liu K, Hong Y, Gao Q, Huang J, Liu L, Li	Cellular and molecular life sc	2026	0
Clonal Hematopoiesis in Cardiovascular Risk: Focus on Inflammatory Mechanisms. [PMID:41899316]	["Sinnadurai S", "Honigberg M", "Meijers	Journal of clinical medicine	2026	0
Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxic Effects. [PMID:41926089]	Park CS, Ryu G, Ahn HJ, Sun C, Lee SP, K	JAMA oncology	2026	0
Rhodiola sacra Protects Against Hippocampal Neuronal Apoptosis in Chronic Cerebr [PMID:41879438]	Zhou L, Jia J, Li J, Yao Z, Fu Z, Wang S	Current neuropharmacology	2026	0
Mechanistic Modulation of Autophagy by Bioactive Natural Products: Implications [PMID:41830033]	Jalouli M, Harrath AH, Al-Zharani M, Rah	Nutrients	2026	0
Chimeric antigen receptor T-cell therapies related to immune effector cell-assoc [PMID:41914034]	Zhang Y, Yang J, Xin H, Ai K, Yang M, Li	Chinese medical journal	2026	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning EPIGENETIC in their description or question text

Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Epigenetically Restores Claudi

Score: 0.712 · unknown disease · 2026-04-26

Gut dysbiosis-driven butyrate deficit causes HDAC-mediated silencing of CLDN5 in brain endothelial cells; tributyrin pro

Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration

Score: 0.701 · neurodegeneration · 2026-04-02

## Mechanistic Overview Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration starts from the claim that modulating SI

NAD+ Decline and SIRT1 Deficiency Drive Epigenetic Reprogramming Toward Senescen

Score: 0.700 · neurodegeneration · 2026-04-22

## **Molecular Mechanism and Rationale** The molecular foundation of this hypothesis centers on the intricate relations

Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromatin Remodeling

Score: 0.690 · neurodegeneration · 2026-04-04

## Mechanistic Overview Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromatin Remodeling starts from the claim

FOXO3-Longevity Pathway Epigenetic Reprogramming

Score: 0.672 · neurodegeneration · 2026-04-02

## Mechanistic Overview FOXO3-Longevity Pathway Epigenetic Reprogramming starts from the claim that modulating FOXO3 wit

EV-Mediated Epigenetic Reprogramming

Score: 0.665 · neurodegeneration · 2026-04-11

## **Molecular Mechanism and Rationale** Extracellular vesicles (EVs) represent a sophisticated intercellular communica

EV-Mediated Epigenetic Reprogramming

Score: 0.661 · neurodegeneration · 2026-04-11

**Molecular Mechanism and Rationale** Extracellular vesicles (EVs) represent a sophisticated intercellular communicatio

NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinflammation Through Ep

Score: 0.650 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The molecular foundation of this therapeutic approach centers on the dual functio

Loss of Homeostatic Epigenetic Identity Reprograms Microglia to Dystrophic State

Score: 0.650 · neurodegeneration · 2026-04-22

## Mechanistic Overview Loss of Homeostatic Epigenetic Identity Reprograms Microglia to Dystrophic State starts from the

ELF2-Mediated OPC Epigenetic Drift Drives Region-Dependent Myelin Dysfunction

Score: 0.650 · Alzheimer disease · 2026-04-24

## Mechanistic Overview ELF2-Mediated OPC Epigenetic Drift Drives Region-Dependent Myelin Dysfunction starts from the cl

Epigenetic Reprogramming of Microglial Memory

Score: 0.647 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Epigenetic Reprogramming of Microglial Memory starts from the claim that modulating DNMT3A, HDAC

Epigenetic Silencing of AIF1 Gene Locus by Chronic Inflammation

Score: 0.643 · neuroinflammation · 2026-04-21

## **Molecular Mechanism and Rationale** The epigenetic silencing of the AIF1 (Allograft Inflammatory Factor 1) gene lo

Partial OSK Reprogramming Reverses Epigenetic Aging Without Dedifferentiation

Score: 0.630 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** Partial OSK reprogramming operates through the controlled expression of three Yam

Epigenetic Bivalency at CDKN2A Locus Distinguishes Senescent from Activated Micr

Score: 0.630 · neurodegeneration · 2026-04-22

## Mechanistic Overview Epigenetic Bivalency at CDKN2A Locus Distinguishes Senescent from Activated Microglia starts fro

Senescence-Associated Epigenetic Phenotype (SEP)

Score: 0.620 · neurodegeneration · 2026-04-25

Senescence-Associated Epigenetic Phenotype (SEP)